comparison of glp 1 receptor agonists Frontiers GLP1 Receptor Agonists vs SGLT2-I
Description
Follow-up labs are typically recommended at 3 months, 6 months, and then every 6 to 12 months during treatment
Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T
Available at: Accessed February 2nd, 2024 Blue cross blue shield blue care network of Michigan
In Phase 3 trials, more than half of patients lost over 10% of their body weight in 6 months
Infusion maintains a steady-state drug concentration in the bloodstream, which is crucial for studying pharmacokinetics without the fluctuations seen with bolus dosing
